Regeneron Pharmaceuticals, Inc Jobs and Salary Info

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. The company's products include EYLEA injection for the treatment of wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion; Praluent injection, an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; and Dupixent injection, a monoclonal antibody for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.